German pharmaceuticals group Bayer has stepped up its pursuit of Monsanto and offered $65bn for the controversial maker of genetically modified seeds.
Bayer had already proposed the largest all-cash takeover in history with an offer of $125 a share and said it was now willing to raise its bid to $127.50.
But one major investor raised concerns about the effect on Bayer’s pharmaceuticals strategy and the combined company’s potential debt pile. Industry pundits also warned that the deal might not be worth doing once competition authorities have imposed their conditions.
In a statement, Monsanto said it had taken part in constructive discussions with Bayer about a new offer, the third since May, valuing the St Louis-based firm at $65bn.
Bayer’s proposal will create a global pharmaceutical and farm supplies giant, just as rival firms are consolidating. ChemChina agreed earlier this year to buy Switzerland’s Syngenta for $43bn, after the latter rejected takeover approaches from Monsanto. US firms Dow Chemical and DuPont are pursuing a $130bn merger, to be followed by a breakup into three businesses.
Full Content: The Guardian
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
NFL Executive Escapes Testifying in High-Stakes Trial Over Televised Games
May 16, 2024 by
CPI
EU Consumers Lodge Complaint Against Chinese Retailer Temu Over Content Rules Breach
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI